| Status: Excluded | |
Product meets AWMSG exclusion criteria due to NICE appraisal ID4008: Zilucoplan for treating antibody positive generalised myasthenia gravis ID4008 |
|
Medicine details |
|
| Medicine name | zilucoplan |
| Formulation | subcutaneous injection |
| Reference number | 4568 |
| Indication | Treatment of generalized myasthenia gravis |
| Company | Ra Pharmaceuticals |
| BNF chapter | Musculoskeletal & joint diseases |
| Submission type | N/A |
| Status | Excluded |
| Date of issue | 17/03/2023 |
| NICE guidance | ID4008: Zilucoplan for treating antibody positive generalised myasthenia gravis ID4008 |